ResultsIQ › Latest results › Alkyl Amines Chemicals Limited
Alkyl Amines Chemicals Limited Q4 FY26 earnings call summary
NSE: ALKYLAMINE · BSE: 506767
Earnings call of 6 May 2026, summarised by AI from the filing.
Alkyl Amines FY26 revenue and profit flat, guides 5-10% volume growth next year amid ammonia price surge.
Key takeaways
- Flat results Top line and bottom line remained flat, plus/minus 1% of last year; volume dropped about 1%.
- Guidance Management expects 5% to 10% volume growth next year and some improvement in margins.
- Ammonia price Ammonia price rose from about ₹50 per kg to over ₹100 per kg, passed on to customers.
- Chinese competition Chinese reduced aggressiveness in last quarter, helping acetonitrile pricing and market share.
- Methylamine overcapacity New player Aarti commissioned plant, adding overcapacity and competition in methylamines.
Alkyl Amines Chemicals Limited Q1 FY27 results
As filed: Revenue ₹528 cr (+30% year on year), EBITDA ₹134 cr (+76% year on year), PAT ₹94.6 cr (+93% year on year), EBITDA margin 25.3% (+658 bps).
The Q1 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹387 cr (0% year on year), EBITDA ₹70.7 cr (+4% year on year), PAT ₹45.4 cr (−1% year on year), EBITDA margin 18.3% (+65 bps). Score 46 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was below it. EBITDA margin rose 65 bps year on year. Share price after the results: +14.0% in 30 days (Nifty 500: −1.5%).
- Q3 FY26: Revenue ₹354 cr (−5% year on year), EBITDA ₹67.2 cr (−5% year on year), PAT ₹42.3 cr (−4% year on year), EBITDA margin 19.0% (−17 bps). Score 40 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 17 bps year on year. Revenue fell 9% from last quarter. Share price after the results: −10.0% in 30 days (Nifty 500: −0.6%).
- Q2 FY26: Revenue ₹389 cr (−6% year on year), EBITDA ₹70.0 cr (−4% year on year), PAT ₹43.0 cr (−9% year on year), EBITDA margin 18.0% (+40 bps). Score 39 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin rose 40 bps year on year. Revenue fell 4% from last quarter. Share price after the results: −12.3% in 30 days (Nifty 500: −0.3%).
- Q1 FY26: Revenue ₹406 cr (+2% year on year), EBITDA ₹76.0 cr (−4% year on year), PAT ₹49.0 cr (0% year on year), EBITDA margin 18.7% (−103 bps). Score 41 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 103 bps year on year. Share price after the results: −3.0% in 29 days (Nifty 500: +2.2%).
- Q4 FY25: Revenue ₹386 cr (+8% year on year), EBITDA ₹68.0 cr (0% year on year), PAT ₹46.0 cr (+21% year on year), EBITDA margin 17.6% (−143 bps). Score 48 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was below it; profit growth was in line with it. EBITDA margin fell 143 bps year on year. Share price after the results: +18.1% in 28 days (Nifty 500: +6.1%).
- Q3 FY25: Revenue ₹371 cr (+15% year on year), EBITDA ₹71.0 cr (+20% year on year), PAT ₹44.0 cr (+33% year on year), EBITDA margin 19.1% (+81 bps). Score 63 of 100, In line with trend. Revenue, EBITDA and profit growth were above the company's own trend. EBITDA margin rose 81 bps year on year. Revenue fell 11% from last quarter.
- Q2 FY25: Revenue ₹415 cr (+18% year on year), EBITDA ₹73.0 cr (+49% year on year), PAT ₹47.0 cr (+74% year on year), EBITDA margin 17.6% (+367 bps). Score 85 of 100, Above trend. EBITDA margin rose 367 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 4% from last quarter.
Past price moves after results do not indicate future moves. Not a recommendation.
Alkyl Amines Chemicals Limited earnings call, investor presentation and press release summaries
- Q4 FY26: Earnings call (6 May 2026)
- Q2 FY26: Earnings call (6 Nov 2025)
- Q4 FY25: Earnings call (12 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.